Wayne L Furman

6PUBLICATIONS
52CO-AUTHORS
Radiation therapyHaematological tumoursGene and molecular therapyNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2026
Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group.

|Dec 07, 2021
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

Angela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan

|Dec 06, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.

Wayne L Furman, Beth McCarville, Barry L Shulkin

|Jun 17, 2021
Monoclonal Antibody Therapies for High Risk Neuroblastoma.

Wayne L Furman

|Jan 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors.

Victor M Santana, Natasha Sahr, Ruth G Tatevossian

|Jan 11, 2020
Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort.

Carmen L Wilson, Tara M Brinkman, Cathleen Cook

Pageof 1

Frequent Collaborators

2 joint publications

Paul Sondel

2 joint publications

Elizabeth B McCarville

2 joint publications

Matthew Krasin

2 joint publications

Alice Yu